[Y\]^^M^^arj^^^M: Cose Study Series \dmoA^m\sit^ C o l l a b o r a t o r : Mid-sized pharmaceutical company. D e t a i l s : AMRI initially assigned four full-time equivalents (FTEs) to the relationship, which grew to a maximum of over 40 FTEs over a three-year period.
\\
Outcomes: • Substantial utilization of medicinal chemistry, computational chemistry, parallel synthesis,analytical chemistry,and separations groups. • Contributed to nine discovery projects, resulting in several advanced IND track candidates and clinical lead candidates.
Call AMRI today to learn how we can help your drug research efforts.
• Thousands of compounds prepared. Milligram to multiple kilogram synthesis. • SAR,QSAR analysis routinely used.
21 Corporate Circle, P.O. Box 15098 Albany, NY 12212-5098 Phone:518-464-0279 • Fax:518-464-0289
• Patents, publications, posters and presentations publicly demonstrate results and contributions of AMRI scientists.
[email protected] • www.albmolecular.com
1 * 1
''**®$S!0Wm^:F?(::''
' -^
Visit www.albmolecular.comlfeatureslcatalog for more compounds
21 Corporate Circle, P.O. Box 15098 • Albany, NY 12212-5098 Phone: 877-388-4675x5151 • Fax:315-458-9293 •
[email protected] • www.albmolecular.com
